Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803699 · ClinicalTrials.gov registry record · NA
Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT00803699: Completed NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT00803699 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00803699, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
In this study, we will evaluate the effectiveness of several doses of oral selenomethionine in raising biomarkers of selenium status including plasma selenium concentrations.
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT selenium as L-selenomethionine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00803699 record still lists
NCT00803699 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00803699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00803699 about?
NCT00803699 is a clinical study titled "Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels". In this study, we will evaluate the effectiveness of several doses of oral selenomethionine in raising biomarkers of selenium status including plasma selenium concentrations.
What is the current status of trial NCT00803699?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2005-11. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00803699?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), selenium as L-selenomethionine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00803699?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00803699's enrollment target sits among peer trials
262 397th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia